Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin L Jones

Showing results (271-280 of 393) with videos related to

Pageof 40
Sort By:
British Journal of Cancer|March 10, 2020
Imatinib in combination with phosphoinositol kinase inhibitor buparlisib in patients with gastrointestinal stromal tumour who failed prior therapy with imatinib and sunitinib: a Phase 1b, multicentre studyHans Gelderblom, Robin L Jones, Suzanne George, et al.
Anticancer Research|September 15, 2019
The Role of Local Therapy in Multi-focal Epithelioid HaemangioendotheliomaDaniel Tong, Anastasia Constantinidou, Bodil Engelmann, et al.
Cancer|February 24, 2012
NY-ESO-1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcomaSeth M Pollack, Achim A Jungbluth, Benjamin L Hoch, et al.
Sarcoma|December 27, 2013
Clinical activity and tolerability of a 14-day infusional Ifosfamide schedule in soft-tissue sarcomaJuan Martin-Liberal, Salma Alam, Anastasia Constantinidou, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 15, 2010
PPM1D gene amplification and overexpression in breast cancer: a qRT-PCR and chromogenic in situ hybridization studyMaryou B Lambros, Rachael Natrajan, Felipe C Geyer, et al.
Plos One|December 7, 2020
The route to diagnosis of sarcoma patients: Results from an interview study in the Netherlands and the United KingdomVicky L M N Soomers, Winette T A van der Graaf, Shane Zaidi, et al.
Medical Oncology (Northwood, London, England)|August 22, 2018
Poor treatment outcomes with palliative gemcitabine and docetaxel chemotherapy in advanced and metastatic synovial sarcomaAlexandra Pender, Elizabeth J Davis, Dharmisha Chauhan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 24, 2026
In DeFi-ance of "More Is Better": Questioning Long-Term Nirogacestat Use in Desmoid TumorsFahima Dossa, Chandrajit P Raut, Andrew J Wagner, et al.
Acta Oncologica (Stockholm, Sweden)|June 11, 2025
Real-world data on immune checkpoint inhibitors in advanced sarcomas across multiple European institutionsStefania Kokkali, Ana Dolcan, Kjetil Boye, et al.
Cardiovascular Toxicology|July 3, 2009
Report and recommendations of the workshop of the European Centre for the Validation of Alternative Methods for Drug-Induced CardiotoxicityTina C Stummann, Mario Beilmann, Göran Duker, et al.
Pageof 40

Showing results (271-280 of 393) with videos related to

Sort By:
Pageof 40
British Journal of Cancer|March 10, 2020
Imatinib in combination with phosphoinositol kinase inhibitor buparlisib in patients with gastrointestinal stromal tumour who failed prior therapy with imatinib and sunitinib: a Phase 1b, multicentre studyHans Gelderblom, Robin L Jones, Suzanne George, et al.
Anticancer Research|September 15, 2019
The Role of Local Therapy in Multi-focal Epithelioid HaemangioendotheliomaDaniel Tong, Anastasia Constantinidou, Bodil Engelmann, et al.
Cancer|February 24, 2012
NY-ESO-1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcomaSeth M Pollack, Achim A Jungbluth, Benjamin L Hoch, et al.
Sarcoma|December 27, 2013
Clinical activity and tolerability of a 14-day infusional Ifosfamide schedule in soft-tissue sarcomaJuan Martin-Liberal, Salma Alam, Anastasia Constantinidou, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 15, 2010
PPM1D gene amplification and overexpression in breast cancer: a qRT-PCR and chromogenic in situ hybridization studyMaryou B Lambros, Rachael Natrajan, Felipe C Geyer, et al.
Plos One|December 7, 2020
The route to diagnosis of sarcoma patients: Results from an interview study in the Netherlands and the United KingdomVicky L M N Soomers, Winette T A van der Graaf, Shane Zaidi, et al.
Medical Oncology (Northwood, London, England)|August 22, 2018
Poor treatment outcomes with palliative gemcitabine and docetaxel chemotherapy in advanced and metastatic synovial sarcomaAlexandra Pender, Elizabeth J Davis, Dharmisha Chauhan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 24, 2026
In DeFi-ance of "More Is Better": Questioning Long-Term Nirogacestat Use in Desmoid TumorsFahima Dossa, Chandrajit P Raut, Andrew J Wagner, et al.
Acta Oncologica (Stockholm, Sweden)|June 11, 2025
Real-world data on immune checkpoint inhibitors in advanced sarcomas across multiple European institutionsStefania Kokkali, Ana Dolcan, Kjetil Boye, et al.
Cardiovascular Toxicology|July 3, 2009
Report and recommendations of the workshop of the European Centre for the Validation of Alternative Methods for Drug-Induced CardiotoxicityTina C Stummann, Mario Beilmann, Göran Duker, et al.
Pageof 40